Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease

Program Overview

Asthma is one of the most common chronic diseases of childhood. While most children achieve asthma control, some develop severe and persistent disease that cannot be controlled with standard treatment options. Evolution in our understanding of asthma biology has led to the development of novel targeted therapies that target the underlying mechanisms of disease, several of which are now available for pediatric patients. This interactive activity combines artistic design, infographic presentation, and scientific expertise to deliver the latest advances in treatment of pediatric asthma, including current treatment guidelines, identifying poorly-controlled disease, and incorporating novel biologic therapy into the management of pediatric patients with asthma.

Credit Expired

CE Credit Expired

Expires: January 29, 2021

Target Audience

This activity is designed for allergy/immunology and pulmonology providers, including physicians, nurse practitioners, and physician assistants who manage pediatric patients with asthma.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Incorporate current recommended treatment algorithms into the care of pediatric patients with asthma
Identify children with poorly-controlled asthma for whom treatment escalation may be appropriate
Integrate newer and more effective treatments for children with resistant or moderate-to-severe asthma based on safety and efficacy data and different asthma endotypes

Activity Faculty

Michael E. Wechsler, MD, MMSc

Co-Director, The Cohen Family Asthma Institute
Professor, Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 